PT  - JOURNAL ARTICLE
AU  - Ian Pavord
AU  - Thomas Bahmer
AU  - Fulvio Braido
AU  - Borja G. Cosío
AU  - Marc Humbert
AU  - Marco Idzko
AU  - Lukasz Adamek
TI  - Severe T2-high asthma in the biologics era: European experts' opinion
AID  - 10.1183/16000617.0054-2019
DP  - 2019 Jun 30
TA  - European Respiratory Review
PG  - 190054
VI  - 28
IP  - 152
4099  - http://err.ersjournals.com/content/28/152/190054.short
4100  - http://err.ersjournals.com/content/28/152/190054.full
SO  - EUROPEAN RESPIRATORY REVIEW2019 Jun 30; 28
AB  - The European Respiratory Biologics Forum gathered participants from 21 countries in Madrid, Spain, to discuss the management and treatment of severe asthma in the era of biologics. The current insights on the pathophysiology of severe asthma were discussed, as well as the role of respiratory biologics in clinical practice and strategies for eliminating chronic use of oral corticosteroids. The participants also highlighted the key challenges in identifying patients with severe asthma based on phenotypes, biomarkers and treatable traits, and the existing problems in patient referral to specialist care. The monitoring of treatment was debated and the need for a change towards precision medicine and personalised care was emphasised throughout the meeting. This review provides a summary of the discussions and highlights important concerns identified by the participants regarding the current management of severe asthma.This review provides a summary of the discussions and highlights important concerns identified by the participants of the European Respiratory Biologics Forum on the current management of severe asthma. http://bit.ly/2YhpP1k